Lufina E. Tsirizani
Blantyre, S, Malawi
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.
Journal: Microbiology spectrum
Published: January 08, 2026
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: September 26, 2025
Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin-resistant tuberculosis.
Journal: British journal of clinical pharmacology
Published: July 24, 2025
The effect of pregnancy on the population pharmacokinetics of levofloxacin in South Africans with rifampicin-resistant tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: April 01, 2025
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Infectious diseases
Published: July 04, 2024
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV.
Journal: The Journal of antimicrobial chemotherapy
Published: June 03, 2024
Compensation of subjects for participation in biomedical research in resource - limited settings: a discussion of practices in Malawi.
Journal: BMC medical ethics
Published: December 18, 2018
Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: March 08, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026